bibliographicCitation |
Fury MG, Haque S, Stambuk H, Shen R, Carlson D, Pfister D. A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer. Cancer. 2011 Feb 15;117(4):795–801. doi: 10.1002/cncr.25464. PMID: 20922785. |